DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
CS-3150 is an investigational drug.
There have been 11 clinical trials for CS-3150. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Hypertension, Renal Insufficiency, and Kidney Diseases. The leading clinical trial sponsors are Daiichi Sankyo Co., Ltd., Daiichi Sankyo Inc., and Daiichi Sankyo, Inc.
There are fourteen US patents protecting this investigational drug and one hundred and eighteen international patents.
Recent Clinical Trials for CS-3150
|Study of CS-3150 in Patients With Primary Aldosteronism||Daiichi Sankyo Co., Ltd.||Phase 3|
|Study of CS-3150 in Patients With Essential Hypertension||Daiichi Sankyo Co., Ltd.||Phase 3|
|Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension||Daiichi Sankyo Co., Ltd.||Phase 3|
Top disease conditions for CS-3150
Top clinical trial sponsors for CS-3150
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|CS-3150||⤷ Try it Free||Method for producing pyrrole derivative, and intermediate thereof||Daiichi Sankyo Company, Limited (Chuo-ku, JP)||⤷ Try it Free|
|CS-3150||⤷ Try it Free||Solid composition of pyrrole carboxamide||Daiichi Sankyo Company, Limited (Chuo-ku, JP)||⤷ Try it Free|
|CS-3150||⤷ Try it Free||Pharmaceutical for prophylaxis or treatment of hypertension||Daiichi Sankyo Company, Limited (Chuo-ku, JP)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|CS-3150||Canada||CA2922350||2033-08-27||⤷ Try it Free|
|CS-3150||China||CN105473552||2033-08-27||⤷ Try it Free|
|CS-3150||European Patent Office||EP3040330||2033-08-27||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|